ATE52186T1 - Aldose-reductase-hemmer, nuetzlich bei der behandlung von glaukom. - Google Patents
Aldose-reductase-hemmer, nuetzlich bei der behandlung von glaukom.Info
- Publication number
- ATE52186T1 ATE52186T1 AT86112137T AT86112137T ATE52186T1 AT E52186 T1 ATE52186 T1 AT E52186T1 AT 86112137 T AT86112137 T AT 86112137T AT 86112137 T AT86112137 T AT 86112137T AT E52186 T1 ATE52186 T1 AT E52186T1
- Authority
- AT
- Austria
- Prior art keywords
- glaucoma
- reductase inhibitor
- useful
- treatment
- aldose reductase
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP86112137A EP0258476B1 (de) | 1986-09-02 | 1986-09-02 | Aldose-Reductase-Hemmer, nützlich bei der Behandlung von Glaukom |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE52186T1 true ATE52186T1 (de) | 1990-05-15 |
Family
ID=8195385
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT86112137T ATE52186T1 (de) | 1986-09-02 | 1986-09-02 | Aldose-reductase-hemmer, nuetzlich bei der behandlung von glaukom. |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP0258476B1 (de) |
| AT (1) | ATE52186T1 (de) |
| DE (1) | DE3670570D1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0384416B1 (de) * | 1989-02-22 | 1993-11-03 | Sanwa Kagaku Kenkyusho Co., Ltd. | Pharmazeutische Zusammensetzung, die ein Hydantoin-Derivat enthält |
| GB8917323D0 (en) * | 1989-07-28 | 1989-09-13 | Inverni Della Beffa Spa | Methods and pharmaceutical compositions for the treatment of ophthalmic diseases |
| AU2008210970B2 (en) * | 2007-01-31 | 2012-11-29 | Sanwa Kagaku Kenkyusho Co., Ltd. | Protective agent for retinal nerve or optic nerve |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0136143B1 (de) * | 1983-09-23 | 1987-11-04 | Pfizer Inc. | Spirosuccinimide und ihre Anwendung in der Behandlung von Zuckerkrankheitskomplikationen |
| US4609663A (en) * | 1984-09-11 | 1986-09-02 | Alcon Laboratories, Inc. | Aldose reductase inhibitors useful in glaucoma therapy |
-
1986
- 1986-09-02 AT AT86112137T patent/ATE52186T1/de active
- 1986-09-02 DE DE8686112137T patent/DE3670570D1/de not_active Expired - Lifetime
- 1986-09-02 EP EP86112137A patent/EP0258476B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0258476B1 (de) | 1990-04-25 |
| EP0258476A1 (de) | 1988-03-09 |
| DE3670570D1 (de) | 1990-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO862528D0 (no) | Metode for aa forhindre ocular hypertensjon, behandling av glaucoma og behandling av ocular hypertensjon. | |
| DK0735019T3 (da) | Retrovirale proteaseinhibitorer | |
| NO162124C (no) | Forspent bjelke av trevirke. | |
| NO881697D0 (no) | Verktoeyenhet, verktoeydeler og fremgangsmaate for sammensetting av delene. | |
| DE69233041D1 (de) | Behandlung von amplifizierter DNS mit alkalischer Phosphatase | |
| DK283881A (da) | Fremgangsmaade til fremstilling af pyrazinyl1,2,4-oxadiazol-5-oner | |
| DE3584174D1 (de) | Rheumamittel. | |
| DK0436199T3 (da) | Cyklopropylderivatlipoxygenaseinhibitorer | |
| DE3851533D1 (de) | Behandlung von klimaanlagen. | |
| ES2082872T3 (es) | Composiciones antiglaucoma que contienen 3-arilcarbonil-1-aminoalquil--1h-indol. | |
| IT1240486B (it) | Procedimento di ammollo enzimatico per pelli e pellami. | |
| DK67683A (da) | Fremgangsmaade til fremstilling af 2,3-diaryl-5-halogen-thio-phener | |
| ATE52186T1 (de) | Aldose-reductase-hemmer, nuetzlich bei der behandlung von glaukom. | |
| DE3777656D1 (de) | Mittel zur behandlung von alopezien. | |
| DE68908344D1 (de) | Oberflaechenbehandlung von metallen. | |
| DE3576689D1 (de) | Oxa- und thiadiazolylderivate und ihre verwendung. | |
| DE58909244D1 (de) | Verwendung von 1,4-Dihydropyridin-Derivaten in der Behandlung von Alkoholsucht. | |
| DE3765583D1 (de) | Oberflaechenbehandlungsmittel und -verfahren. | |
| DE68922653D1 (de) | Herstellungsverfahren von Metall-Halbleiter Feldeffekttransistoren. | |
| ATE241359T1 (de) | Topische und systemische anwendung von buspiron und seinen derivaten zur behandlung von pathologischen zuständen, die mit immunantworten verbunden sind | |
| DK205188D0 (da) | Proteinprotease-inhibitorer af streptomyces | |
| DE69021584D1 (de) | Behandlung von abgas. | |
| DE3586582D1 (de) | Durch elektronen gepumpter halbleiterlaser und vorrichtung. | |
| DE3576498D1 (de) | 2-sulfamoyl-1h-indole-derivate zur behandlung von hohem intraocularem druck. | |
| DE68906026D1 (de) | Behandlung von metallbrammen. |